Annual Drug Patent Expirations for ORAVERSE
Oraverse is a drug marketed by Septodont Holding and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixteen patent family members in twelve countries.
The generic ingredient in ORAVERSE is phentolamine mesylate. One supplier is listed for this compound. Additional details are available on the phentolamine mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
